http://goldbamboo.com/ Familial Hemangioma News from GoldBamboo.com en-us © 2005, Gold Bamboo LLC, All Rights Reserved http://goldbamboo.com/news-a222393.html Among patients with retinal disease, molecular testing can confirm a clinical diagnosis of hereditary disorders, identify carrier status and confirm or rule out the presence of a familial mutation in those without symptoms, according to a report in the February issue of Archives of Ophthalmology, one of the JAMA/Archives journals. Fri, 23 Feb 2007 04:00 EST http://goldbamboo.com/news-a221393.html The first results from a scan of the world's largest collection of DNA samples from families affected by autism point to two new genetic links that may predispose people to the brain disorder. Nature Genetics reports the study's findings in its Feb. 18 online edition. [click link for full article] Mon, 19 Feb 2007 08:00 EST http://goldbamboo.com/news-a220913.html Among patients with retinal disease, molecular testing can confirm a clinical diagnosis of hereditary disorders, identify carrier status and confirm or rule out the presence of a familial mutation in those without symptoms, according to a report in the February issue of Archives of Ophthalmology, one of the JAMA/Archives journals. [click link for full article] Thu, 15 Feb 2007 05:00 EST http://goldbamboo.com/news-a213276.html Pancreatic cancer is relatively rare but deadly; most patients die within a year of diagnosis, and it is the fourth leading cause of cancer deaths in the US. At least 10% of pancreatic cancers are thought to be familial, i.e., caused by inherited genetic mutations. [click link for full article] Thu, 28 Dec 2006 08:00 EST http://goldbamboo.com/news-a215861.html Researchers at the University of Pennsylvania School of Medicine have demonstrated the potential of a new type of therapy for patients who suffer from high cholesterol levels. The findings are in the January 11 issue of the New England Journal of Medicine (NEJM). In this study, patients with homozygous familial hypercholesterolemia (FH), a high-risk condition refractory to conventional therapy, had a remarkable 51 percent reduction in low-density lipoprotein (LDL) or "bad cholesterol" levels. Tue, 16 Jan 2007 04:00 EST